Drug
Erythromycin Lactobionate
Erythromycin Lactobionate: highest development phase Approved, developed by Abbott Laboratories. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Abbott Laboratories
Trials
| Drug | Phase | Indication |
|---|---|---|
| ERYTHROCIN | Approved |
Latest
No recent events.
Follow Erythromycin Lactobionate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.